Daniel C. Javitt

Dr. Javitt is a Professor in the Department of Psychiatry and Neuroscience at the Columbia University College of Physicians and Surgeons. He was an early proponent of the NMDA model of schizophrenia and is a leader in NMDA-based treatment development. He has published more than 250 original research articles on topics related to schizophrenia and serious psychiatric illnesses, with more than 4400 cumulative citations. He has received numerous honors for his work, including research awards from the American Psychiatric Association, the American College of Neuropsychopharmacology, the Society for Biological Psychiatry, and the Child Welfare League of America. His research is supported by the National Institute for Mental Health, the National Institute on Drug Abuse, the Stanley Foundation, and other philanthropic organizations. He currently serves as associate editor of Schizophrenia Bulletin, and as an editorial board member for several prestigious journals, including Schizophrenia Research and the American Journal of Psychiatry. Dr. Javitt is a Fellow of the American College of Neuropsychopharmacology, an advisory board member for the Brian and Behavior Research Foundation and a standing member of the Institute of Medicine Neuro Forum. Dr. Javitt received his M.D. and Ph.D. from the Albert Einstein College of Medicine and completed his fellowship and residency at the Albert Einstein Medical Center.